Iterum Therapeutics PLC reports results for the quarter ended in September - Earnings Summary

Iterum Therapeutics

12/11/2021 14:31

* Iterum Therapeutics PLC  ITRM.OQ  reported quarterly adjusted
earnings of 2 cents​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for earnings of 12 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Iterum Therapeutics PLC's reported EPS for the quarter was 2
cents​.
* The mean earnings estimate of analysts had risen by about 4.3%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Iterum Therapeutics PLC shares had risen by 9.1% this
quarter and lost 38.4% so far this year.
* The company reported quarterly net income of $3.74 million.
* Wall Street's median 12-month price target for Iterum
Therapeutics PLC is $1.00 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 12 at 02:31 p.m.
 ​All figures in US dollars unless otherwise stated